Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke

Stroke Clinical Trial

— MAASP  

Official title:

Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT02171858
• Other study ID #: CRP-S1
• Status: Enrolling by invitation
• Phase: N/A
• First received: June 4, 2014
• Last updated: June 21, 2014
• Start date: June 2013

Study information

• Verified date: June 2014
• Source: Hospital Central Sur de Alta Especialidad
• Contact: n/a
• Is FDA regulated: No
• Health authority: Mexico: Secretaria de Salud
• Study type: Observational

Clinical Trial Summary

Stroke is one of main causes of death and impairment worldwide. Objective of this study is to analyze serum High Sensitivity C-Reactive Protein in acute phase stroke in patients attended at Petróleos Mexicanos Hospital Central Sur de Alta Especialidad and to correlate with stroke extension and clinical features.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 28
• Est. primary completion date: January 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients suspected of acute phase stroke who arrive to emergency room at our hospital

• Patients affiliated to Petróleos Mexicanos medical system

• Patients of any gender

• Patients between 18 and 80 years old

Exclusion Criteria:

• Stroke provoked by angiographic procedure

• Pregnancy

• Patient under chemotherapy or radiotherapy

• Recently surgery or trauma among last 30 days

• Heparin usage

• Stroke and/ or thrombolysis history

• Active infection

• Liver disease

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• National Institutes of Health Stroke Scale
• Serum High Sensitivity C-Reactive Protein
• Stroke

Locations

Country	Name	City	State
Mexico	Hospital Central Sur Alta Especialidad	Mexico city	Tlalpan

Sponsors (1)

Lead Sponsor	Collaborator
Hospital Central Sur de Alta Especialidad

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Stroke extension	brain image will be taken as soon as possible when patient suspected with stroke arrives to emergency room and after clinical evaluation	within the first 4 hours since admission to emergency room	No
Other	Origin of stroke	origin of stroke will be investigated within hospital stay	origin will be diagnosed during the hospital stay expecting no more than 1 week	No
Other	Hospital stay	from arrival of patient to emergency room until discharge	hospital stay is expected for no more than 1 week unless intensive care unit is needed	No
Primary	Measure of serum High sensitivity C-Reactive Protein level	Serum levels of serum High sensitivity C-Reactive Protein will be measured in patients with suspicion of stroke at the emergency room within the first 8 hours of arrival at our hospital	within the first 8 hours since admission to hospital	No
Secondary	National Institutes of Health Stroke Scale	clinical impact of stroke will be determined by neurology and neurosurgery department at admission to emergency room of our hospital	within the first 4 hours since admission to emergency room	No